Featuring Contributions From:

Astra Zeneca

Guillermo Arvizu
Institutional Business Head
AstraZeneca

Janssen

Olga Bogdanovich
Sales and Operations Analytics Manager
Janssen

Takeda

Andre Bortoluci Vicente
Market Access Group Manager
Takeda

Bayer

Rafael Quintanilla Chong
Director of Bayer's Primary Care Business Unit
Bayer

UCB

Daniel Ghozzi
Managing Director for the Commonwealth of Independent States
UCB

Glenmark

Carlos Grzelak. Jr
Sales and Marketing Director
Glenmark

Johnson_and_Johnson

Pauline Ho, Consultant at AuPATH LLC & former VP, Strategic Marketing, Latin America and Asia-Pacific
Johnson & Johnson

Merck

Alberto Jaimes
National Sales Manager
Merck

Corporate Law Group

Rajashree Sharma
Partner
Corporate Law Group

Sanofi-Aventis

Rogerio Sperb
Insulin Marketing Manager
Sanofi-Aventis

Merck

Bhavesh Vyas
Regional Sales Manager
Merck

Ricerca Biosciences

Dr Susan Wang
Strategic Director
Ricerca Biosciences


Peer Reviewed By:

The report from eyeforpharma on the BRICM markets is an excellent overview based on interviews with country experts, offering a quick snapshot of the current state of five countries' pharmaceutical markets, their growth opportunities and real life case studies. As the world becomes ever more connected and the pace of change ever more vertiginous, successful companies are those that are not afraid to confess that they don't know it all, and are continuously pursuing and experimenting with new knowledge to maximise growth. This report provides marketing and sales insights to increasing the odds in succeeding in these fast growing emerging markets
Pauline Ho
Pauline Ho,
Former VP, Strategic Marketing, Latin America and Asia-Pacific, Johnson & Johnson.
Currently Consultant, AuPATH LLC.


View The Exclusive Selected Findings Now
Download Now